Showing posts with label Thomas Insel. Show all posts
Showing posts with label Thomas Insel. Show all posts

Wednesday, January 12, 2011

Understanding Severe Mental Illness


A January 11th posting by the National Institute of Mental Health:
By Thomas Insel (pictured)

When a tragedy occurs like the shooting in Tucson this past weekend, all of us seek an explanation. While there remain many questions, a leading hypothesis is that the suspect has a serious mental illness (SMI), such as schizophrenia. The topic of violence and mental illness is never an easy discussion: with issues such as stigma, incarceration, public safety, and involuntary treatment in the mix. There is a legitimate concern that talking about violence and mental illness in the same sentence increases the likelihood that people with serious illness will be further marginalized and less likely to receive appropriate care. But tragic events, whether at a Safeway in Tucson or a classroom at Virginia Tech, require us to address this uncomfortable subject with the science available.

Is violence more common in people with SMI? Yes, during an episode of psychosis, especially psychosis associated with paranoia and so-called “command hallucinations”, the risk of violence is increased. People with SMI are up to three times more likely to be violent and when associated with substance abuse disorders, the risk may increase much further (1). But, mental illness contributes very little to the overall rate of violence in the community. Most people with SMI are not violent, and most violent acts are not committed by people with SMI. In fact, people with SMI are actually at higher risk of being victims of violence than perpetrators. Teplin et al found that those with SMI are 11 times more likely to be victims of violent crime than the general population (2).

The most common form of violence associated with mental illness is not against others, but rather, against oneself. In 2007, the most recent year for which we have statistics, there were almost 35,000 suicides, nearly twice the rate of homicides. Suicide is the 10th leading cause of death in the United States (3). Although it is not possible to know what prompted every suicide, it is safe to say that unrecognized, untreated mental illness is a leading culprit.

Treatment may be the key to reducing the risk of violence, whether that violence is self-directed or directed at others. Research has suggested that those with schizophrenia whose psychotic symptoms are controlled are no more violent than those without SMI (4). It’s likely that treatment not only helps ease the symptoms of mental illness, but also curbs the potential for violence as well.

As we learn more about the circumstances surrounding the tragedy in Tucson, we should be working harder to ensure people with SMI receive the care they need. Early intervention offers the best hope to prevent more tragedies in the future.

For more information on SMI and other mental health statistics, please visit NIMH’s Statistics page.


References
  1. Swanson JW. Mental disorder, substance abuse, and community violence: an epidemiological approach. In: Monahan J, Steadman HJ, eds. Violence and mental disorder: developments in risk assessment. Chicago: University of Chicago Press, 1994:101-36.

  2. Teplin et al. Crime victimization in adults with severe mental illness. Archives of General Psychiatry. 2005 Aug. 62. 911-921.

  3. Centers for Disease Control and Prevention, National Center for Injury Prevention and Control. Web-based Injury Statistics Query and Reporting System (WISQARS). www.cdc.gov/ncipc/wisqars.

  4. Steadman HJ, Mulvey EP, Monahan J, et al. Violence by people discharged from acute psychiatric inpatient facilities and by others in the same neighborhoods. Arch Gen Psychiatry 1998;55:393-401.

Photo credit

Saturday, October 16, 2010

NIMH Head Urges More Emphasis on Mental Illness as Brain Disorder


An article published in the October 15th edition of Psychiatric News:
By Aaron Levin

To catch up with other medical disciplines that have sharply reduced morbidity and mortality, psychiatry must evolve into “clinical neuroscience” and reconceptualize its understanding of the roots of mental disorders.

Research progress on psychiatric disorders must follow the cues of cardiology and oncology, taking major steps forward to find the causes of psychopathology and develop cures for mental illness, stated the director of the National Institute of Mental Health (NIMH).

“We're in the middle of a revolution,” said Thomas Insel, M.D. [pictured] “We have the chance to change the world—not tomorrow, but by staying on course.”

NIMH has laid out that course over the last few years by shifting its grants in directions that it hopes will produce “disruptive innovations,” said Insel in the inaugural lecture of the George Washington Institute for Neuroscience at George Washington University in Washington, D.C., in September.

The new institute is a multidisciplinary center that promotes research and training in the mechanisms of normal and pathological brain function.

Neuropsychiatric illnesses are the leading cause of years lost to disability or death from noncommunicable causes, noted Insel.

Progress Lags in Psychiatric Illness

Advances in research and changes in practice have cut deaths from heart disease by 63 percent since 1965, but similar progress has not happened for mental illness, he pointed out.

“We have to move the agenda,” he said. “Diagnosis still comes by observation, illness is detected late, prediction is poor, etiology is often unknown, prevention is not well developed, treatment is by trial and error, and there are no cures and no vaccines.”

Prevalence and mortality have not decreased, and the culture surrounding them is sunk in low expectations. “This is the only area of medicine where people don't talk about cure and prevention,” he said.

The burden of mental disorders is magnified by its relatively high prevalence (approximately 6 percent) and the fact that these illnesses are chronic disorders and usually begin early in life.

He suggested three main areas on which neuroscience research needs to concentrate to tackle the large public-health problem that mental illness presents: a renewed emphasis on psychiatric disorders as brain disorders, an increasing recognition of the role of child and adolescent development, and achievement of advances in understanding the genetic basis of mental illness risk factors.

Field May Shift to Clinical Neuroscience

Brain lesions may be the realm of neurology, but psychiatric illness is defined by the physiology of neural circuits in the brain, said Insel. A different approach and different training may be needed to understand and treat those illnesses. In 10 years, he suggested, psychiatry might be better termed “clinical neuroscience.”

He cited the example of Area 25 in the subgenual cingulate, a region that becomes overactive in depression, but where activity declines when depression is treated with an SSRI. Imaging studies show brain changes—but only in treatment responders. Deep brain stimulation (DBS) near Area 25 also turns down activity, he noted, and the research on DBS shows how knowledge gleaned from brain mapping, circuitry, and imaging can converge to improve understanding of disease and its treatment.

Second, mental disorders are also developmental disorders, he pointed out. Many begin before age 15, while normal brain development continues until age 25.

The cortex in patients with attention-deficit/hyperactivity disorder (ADHD) seems to take longer to mature. Individuals with the disorder “end up at the same point but two or three years late,” he said. “So is ADHD a disease of attention and behavior in children, or is it one of cortical maturation? The challenge is to see what is going wrong in the organ of interest.”

Third, while genetics are another key component of mental illness, Insel acknowledged that understanding how hundreds of variations map onto brain pathways is a complex challenge. Many variants express only in the human brain and only during development. Many other genes that contribute to mental illness have not yet been identified.

“We need to move from description to mechanism and to approach all of these problems from many levels: molecular, cellular, systemic, individual, and social,” he said.

Learning which early variations in brain structure, circuitry, and function foretell later disorder might lead to interventions that can prevent the development of frank illness.

Eventually, the foundation of brain circuitry, development, and genetics will support a better understanding of pathophysiology, prevention, and personalized medicine, all leading to Insel's goal of a comprehensive public-health approach to psychiatric disorders.

The George Washington Institute for Neuroscience has scheduled a dozen more lectures by other neuroscience researchers between now and next May.

Information about the George Washington Institute for Neuroscience is posted at www.gwumc.edu/neuroscience.

Photograph by David Hathcox